Nima Mosammaparast, PhD, MD, assistant professor of pathology and immunology at Washington University School of Medicine in St. Louis, has received a five-year, $1.74 million grant from the National Cancer Institute of the National Institutes of Health (NIH) for research titled “Mechanism and Regulation of the DNA Alkylation Damage Response.”
Mosammaparast also received a one-year, $50,000 grant from Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine for research titled “Targeting Deubiquitinases to Modulate Chemoresistance in Glioblastoma.”
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.